Stephanie Roessler

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Future of molecular profiling of human hepatocellular carcinoma
    Stephanie Roessler
    National Cancer Institute, Laboratory of Human Carcinogenesis, Center for Cancer Research, NIH, 37 Convent Drive, Bldg 37, Rm 3044A, Bethesda, MD 20892 4258, USA
    Future Oncol 3:429-39. 2007
  2. ncbi Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival
    Stephanie Roessler
    Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Gastroenterology 142:957-966.e12. 2012
  3. ncbi Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
    Naoki Oishi
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Hepatology 56:1792-803. 2012
  4. ncbi A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients
    Stephanie Roessler
    Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Res 70:10202-12. 2010
  5. ncbi MicroRNA expression, survival, and response to interferon in liver cancer
    Junfang Ji
    Liver Carcinogenesis Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    N Engl J Med 361:1437-47. 2009

Collaborators

Detail Information

Publications5

  1. ncbi Future of molecular profiling of human hepatocellular carcinoma
    Stephanie Roessler
    National Cancer Institute, Laboratory of Human Carcinogenesis, Center for Cancer Research, NIH, 37 Convent Drive, Bldg 37, Rm 3044A, Bethesda, MD 20892 4258, USA
    Future Oncol 3:429-39. 2007
    ..Such an approach will provide mechanistic insight into the pathogenesis of HCC, potentially leading to personalized medicine and the identification of new therapeutic targets...
  2. ncbi Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival
    Stephanie Roessler
    Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Gastroenterology 142:957-966.e12. 2012
    ..We used an integrative approach to identify HCC driver genes, defined as genes whose copy numbers associate with gene expression and cancer progression...
  3. ncbi Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
    Naoki Oishi
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Hepatology 56:1792-803. 2012
    ..We suggest that the specific components of EMT may be exploited as critical biomarkers and clinically relevant therapeutic targets for an aggressive form of stem cell-like ICC...
  4. ncbi A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients
    Stephanie Roessler
    Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Res 70:10202-12. 2010
    ....
  5. ncbi MicroRNA expression, survival, and response to interferon in liver cancer
    Junfang Ji
    Liver Carcinogenesis Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    N Engl J Med 361:1437-47. 2009
    ..Hepatocellular carcinoma is a common and aggressive cancer that occurs mainly in men. We examined microRNA expression patterns, survival, and response to interferon alfa in both men and women with the disease...